News

Apply by November 3, 2023 to the BIH Digital Health Accelerator Program, which provides funding to help you translate your digital health venture.

A team of researchers has uncovered a previously unknown compensatory mechanism found in liver disease. If Kupffer cells (KCs), a specific kind of immune cells found in the liver, become impaired by tissue scarring, immune cells originating in the bone marrow flow to the organ, where they form larger cell clusters to perform the same function.…

A new project funded by the European Union’s Horizon Europe research and innovation programme will develop a framework to improve the reproducibility of scientific research. The project, called iRISE (improving Reproducibility in SciencE), will bring together experts from academia and industry to develop a comprehensive understanding of the drivers…

The BIH research groups "Medical Informatics" and "Meta-Research and Automated Screening" are participating in the European MSCA (Marie Skłodowska-Curie Action) doctoral network "SHARE-CTD", which was selected for funding in March 2023.

In the fight against many common diseases, there is a huge need for safe and effective drugs. Maik Pietzner, a group leader in the Computational Medicine Group at the Berlin Institute of Health at Charité (BIH), sees genes as a key to developing new therapies, because most diseases have a genetic background. Using a sophisticated strategy that…

Bartter syndrome type 3 is the result of several structural variants in the genome. By using long-read sequencing, Janine Altmüller and her team from the Max Delbrück Center, the Berlin Institute of Health at Charité (BIH) and University Hospital Cologne mapped out the rare disease in unprecedented detail. They have now reported their findings in…

In a proof-of-concept test, researchers at the Berlin Institute of Health at Charité (BIH), together with industry partners intel and Sentieon, have been able to increase the speed of computationally intensive genome analyses by up to 14 times. The special feature: Long-read single-cell sequencing was performed via a dedicated cloud rather than…

Conventional vaccines usually contain antigens – components of the respective pathogens – that bind to receptors on the surface of their target cells in order to trigger the disease. Scientists at the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center have now discovered that antigen variants with low receptor binding can be…

The Lindau Nobel Laureate Meetings are annual conferences where some of the brightest minds in science converge to exchange knowledge, foster collaboration, and inspire the next generation of researchers. This year, two young researchers from the BIH took part in the 72nd Lindau Nobel Laureate Meeting that was dedicated to Physiology and Medicine.…